From: Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework
Contextual Characteristics | Overall (n = 22) | Patient-Driven Condition (n = 11) | Standardized Condition (n = 11) | Difference across conditions* |
---|---|---|---|---|
Practice Type: N (%) Federally Qualified Health Centers | 12 (54%) | 5 (45%) | 5 (45%) | p = 1.00 |
Practice Location: N (%) | ||||
 Urban | 17 (77%) | 9 (82%) | 8 (73%) | p = 1.00 |
 Rural | 3 (14%) | 1 (9%) | 2 (18%) |  |
 Suburban | 2 (9%) | 1 (9%) | 1 (9%) |  |
Estimated No. of Diabetes Patients: median (range) | 549 (90–4000) | 500 (90–4000) | 576 (214–2112) | p = 0.48 |
Hispanic/Latino Patients > 10%: N (%) of practices | 10 (67%) | 5 (63%) | 5 (71%) | p = 1.00 |
Minority Patients > 20%: N (%) of practices | 13 (87%) | 5 (71%) | 8 (100%) | p = 0.20 |
Payer Mix: Median (range) | ||||
 Private insurance fee for service (FFS) or preferred provider organization | 11 (3–70) | 12 (3–64) | 10 (5–70) |  |
 Private managed care | 11 (5–35) | 15 (10–20) | 10 (5–35) |  |
  Medicare | 19 (2–60) | 20 (9–30) | 14 (2–60) |  |
  Medicaid | 40 (2–63) | 30 (5–60) | 55 (2–63) |  |
  Other public insurance | 3 (0–5) | 3 (0–5) | 3 (0–5) |  |
  Self-pay or uninsured | 10 (0–92) | 6 (0–92) | 10 (3–36) |  |
  Unknown | 0 (0–10) | 0 (0–10) | 0 (0–5) |  |
  Other | 4 (0–100) | 0 (0–0) | 9 (0–100) |  |
Private (FFS + Managed Care) > (Medicare + Medicaid + Other Pub) | 3 (19%) | 2 (29%) | 1 (11%) | p = 0.55 |
No. Clinicians with prescribing privileges: Median (range) | 8 (2–65) | 7 (2–39) | 8 (3–65) | p = 0.39 |
No. Staff eligible to be health educator: median (range) | 2 (1–6) | 2 (1–6) | 3 (1–6) | p = 0.79 |
Previous experience with SMAs: N (%) | 10 (45%) | 5 (45%) | 5 (45%) | p = 1.00 |